RU2002131174A - COMPOSITION "VITALIZIN-1" FOR PREVENTION OF ATHEROSCLEROSIS, CARDIOVASCULAR DISEASES AND SUPPORT THERAPY OF VIRAL DISEASES - Google Patents

COMPOSITION "VITALIZIN-1" FOR PREVENTION OF ATHEROSCLEROSIS, CARDIOVASCULAR DISEASES AND SUPPORT THERAPY OF VIRAL DISEASES

Info

Publication number
RU2002131174A
RU2002131174A RU2002131174/15A RU2002131174A RU2002131174A RU 2002131174 A RU2002131174 A RU 2002131174A RU 2002131174/15 A RU2002131174/15 A RU 2002131174/15A RU 2002131174 A RU2002131174 A RU 2002131174A RU 2002131174 A RU2002131174 A RU 2002131174A
Authority
RU
Russia
Prior art keywords
composition
atherosclerosis
prevention
diseases
vitalizin
Prior art date
Application number
RU2002131174/15A
Other languages
Russian (ru)
Other versions
RU2217141C1 (en
Inventor
Элизбар Михайлович Балавадзе
Ольга Владимировна Бобрешова
Валерий Васильевич Ермилов
Петр Иванович Кулинцов
Владимир Анатольевич Николаевский
Виктор Станиславович Поляков
Original Assignee
Балавадзе Михаил Элизбарович
Filing date
Publication date
Application filed by Балавадзе Михаил Элизбарович filed Critical Балавадзе Михаил Элизбарович
Priority to RU2002131174A priority Critical patent/RU2217141C1/en
Priority claimed from RU2002131174A external-priority patent/RU2217141C1/en
Application granted granted Critical
Publication of RU2217141C1 publication Critical patent/RU2217141C1/en
Publication of RU2002131174A publication Critical patent/RU2002131174A/en

Links

Claims (2)

1. Состав для профилактики атеросклероза, сердечно-сосудистых заболеваний и поддерживающей терапии вирусных заболеваний, характеризующийся тем, что он содержит аскорбиновую кислоту, и/или аскорбат натрия, и/или аскорбат калия, и/или аскорбат кальция, рутин или кверцетин и L-лизин или L-лизин моногидрат при следующем соотношении компонентов, мас.%:1. Composition for the prevention of atherosclerosis, cardiovascular disease and maintenance therapy of viral diseases, characterized in that it contains ascorbic acid and / or sodium ascorbate, and / or potassium ascorbate, and / or calcium ascorbate, rutin or quercetin and L- lysine or L-lysine monohydrate in the following ratio of components, wt.%: Аскорбиновая кислота, и/илиAscorbic acid, and / or аскорбат натрия, и/или аскорбат калия,sodium ascorbate and / or potassium ascorbate, и/или аскорбат кальция 38-45and / or calcium ascorbate 38-45 Рутин или кверцетин 15-20Rutin or Quercetin 15-20 L-лизин или L-лизин моногидрат ОстальноеL-lysine or L-lysine monohydrate 2. Состав по п.1, отличающийся тем, что он выполнен в виде капсул.2. The composition according to claim 1, characterized in that it is made in the form of capsules.
RU2002131174A 2002-11-20 2002-11-20 Composite "vitalizin-1" for prophylaxis of atherosclerosis, cardiovascular diseases and maintaining therapy in viral diseases RU2217141C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002131174A RU2217141C1 (en) 2002-11-20 2002-11-20 Composite "vitalizin-1" for prophylaxis of atherosclerosis, cardiovascular diseases and maintaining therapy in viral diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002131174A RU2217141C1 (en) 2002-11-20 2002-11-20 Composite "vitalizin-1" for prophylaxis of atherosclerosis, cardiovascular diseases and maintaining therapy in viral diseases

Publications (2)

Publication Number Publication Date
RU2217141C1 RU2217141C1 (en) 2003-11-27
RU2002131174A true RU2002131174A (en) 2004-06-10

Family

ID=32028291

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002131174A RU2217141C1 (en) 2002-11-20 2002-11-20 Composite "vitalizin-1" for prophylaxis of atherosclerosis, cardiovascular diseases and maintaining therapy in viral diseases

Country Status (1)

Country Link
RU (1) RU2217141C1 (en)

Similar Documents

Publication Publication Date Title
NZ508877A (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-L-carnitine and genistein
ECSP085573A (en) COMPOSITION INCLUDING AN ABSORPTION INHIBITOR INCLUDING A CHOLESTEROL ABSORPTION INHIBITOR, A CHOLESTEROL REDUCING HMG-CoA INHIBITOR, A HMG-CoA REDUCTASE INHIBITOR AND A STABILIZING AGENT AND STABILIZING AGENT TAS
EP1734041A3 (en) Platelet ADP receptor inhibitors
MXPA05004247A (en) Chromones and chromone derivatives and uses thereof.
ATE245429T1 (en) ANTITROMBOTIC AGENTS
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
TR200001542T2 (en) Derivatives of the stomach fundus that have relaxing properties (benzodioxane, benzofuran or benzopyran).
HK1060045A1 (en) Formulations comprising ibuprofen and diphenhydramine and the use thereof for the treatment of sleepdisturbances
EA200001191A1 (en) NEW PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND LIFE SUPPORT (MAINTAINING LIFE FUNCTIONS) AND METHOD OF PREPARATION
IS4553A (en) Medicinal preparations containing monoamine oxidase B blockers
AR025790A1 (en) COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF CIRCULATORY DISORDERS, WHICH INCLUDES DERIVATIVES OF L-CARNITINE AND GINKGO BILOBA EXTRACTS
RU2003124299A (en) PHARMACEUTICAL COMPOSITIONS Possessing ANTIBIOTIC ACTIVITY
RU2002131174A (en) COMPOSITION "VITALIZIN-1" FOR PREVENTION OF ATHEROSCLEROSIS, CARDIOVASCULAR DISEASES AND SUPPORT THERAPY OF VIRAL DISEASES
RU2000121062A (en) DISINTEGRATING AGENT
RU2002131175A (en) COMPOSITION "VITALIZIN-2" FOR PREVENTION OF ATHEROSCLEROSIS, CARDIOVASCULAR DISEASES AND SUPPORT THERAPY OF VIRAL DISEASES
TR200101344T2 (en) Antioxidant composition consisting of propionyl L-carnitine and a flavonoid
RU2003126512A (en) ARBIDOL-BASED MEDICINE
JPH03120223A (en) Composition for antiviral drug
NO20010930D0 (en) Free-flowing products including potassium formate
RU2002123815A (en) INHALATION COMPOSITION FOR TREATMENT OF BRONCHIAL ASTHMA
RU2002128714A (en) METHOD FOR PRODUCING SLOW-ACTING CAPSULATED FERTILIZERS
RU99102949A (en) PREPARATION "ANTIGRIPPIN"
RU2001126504A (en) NEUROLEPTIC MEDICINE
HUP0002238A2 (en) Pourable alginate compositions
RU2002129343A (en) CARDIOPLEGIC SOLUTION "INFUZOL"